Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

892 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.
Maltais F, Schenkenberger I, Wielders PLML, Ortiz de Saracho J, Chinsky K, Watkins M, Millar V, Crim C. Maltais F, et al. Among authors: watkins m. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620965145. doi: 10.1177/1753466620965145. Ther Adv Respir Dis. 2020. PMID: 33081606 Free PMC article. Clinical Trial.
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
Dransfield MT, Feldman G, Korenblat P, LaForce CF, Locantore N, Pistolesi M, Watkins ML, Crim C, Martinez FJ. Dransfield MT, et al. Among authors: watkins ml. Respir Med. 2014 Aug;108(8):1171-9. doi: 10.1016/j.rmed.2014.05.008. Epub 2014 Jun 19. Respir Med. 2014. PMID: 24998880 Free article. Clinical Trial.
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.
Maltais F, Bjermer L, Kerwin EM, Jones PW, Watkins ML, Tombs L, Naya IP, Boucot IH, Lipson DA, Compton C, Vahdati-Bolouri M, Vogelmeier CF. Maltais F, et al. Among authors: watkins ml. Respir Res. 2019 Oct 30;20(1):238. doi: 10.1186/s12931-019-1193-9. Respir Res. 2019. PMID: 31666084 Free PMC article. Clinical Trial.
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD.
Crim C, Watkins ML, Bateman ED, Feldman GJ, Schenkenberger I, Kerwin EM, Crawford C, Pudi K, Ho S, Baidoo C, Castro-Santamaria R. Crim C, et al. Among authors: watkins ml. Int J Chron Obstruct Pulmon Dis. 2019 Mar 8;14:615-629. doi: 10.2147/COPD.S190603. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30880951 Free PMC article. Clinical Trial.
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease.
Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J, Wouters EF; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Spruit MA, et al. Among authors: watkins ml. J Am Med Dir Assoc. 2012 Mar;13(3):291-7. doi: 10.1016/j.jamda.2011.06.009. Epub 2011 Jul 21. J Am Med Dir Assoc. 2012. PMID: 21778120
Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?
Rutten EP, Calverley PM, Casaburi R, Agusti A, Bakke P, Celli B, Coxson HO, Crim C, Lomas DA, Macnee W, Miller BE, Rennard SI, Scanlon PD, Silverman EK, Tal-Singer R, Vestbo J, Watkins ML, Wouters EF. Rutten EP, et al. Among authors: watkins ml. Ann Nutr Metab. 2013;63(3):239-47. doi: 10.1159/000353211. Epub 2013 Nov 7. Ann Nutr Metab. 2013. PMID: 24216978
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.
Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Polkey MI, et al. Among authors: watkins ml. Am J Respir Crit Care Med. 2013 Feb 15;187(4):382-6. doi: 10.1164/rccm.201209-1596OC. Epub 2012 Dec 21. Am J Respir Crit Care Med. 2013. PMID: 23262518
Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease.
Wilcox TK, Chen WH, Howard KA, Wiklund I, Brooks J, Watkins ML, Cates CE, Tabberer MM, Crim C. Wilcox TK, et al. Among authors: watkins ml. Health Qual Life Outcomes. 2013 Nov 14;11:196. doi: 10.1186/1477-7525-11-196. Health Qual Life Outcomes. 2013. PMID: 24229361 Free PMC article.
892 results